| Literature DB >> 32030315 |
Anna Żądło-Dobrowolska1, Lucas Hammerer1,2, Tea Pavkov-Keller3, Karl Gruber3, Wolfgang Kroutil1,2.
Abstract
The biocatalytic Friedel-Crafts acylation has been identified recently for the acetylation of resorcinol using activated acetic acid esters for the synthesis of acetophenone derivatives catalyzed by an acyltransferase. Because the wild-type enzyme is limited to acetic and propionic derivatives as the substrate, variants were designed to extend the substrate scope of this enzyme. By rational protein engineering, the key residue in the active site was identified which can be replaced to allow binding of bulkier acyl moieties. The single-point variant F148V enabled the transformation of previously inaccessible medium chain length alkyl and alkoxyalkyl carboxylic esters as donor substrates with up to 99% conversion and up to >99% isolated yield.Entities:
Year: 2019 PMID: 32030315 PMCID: PMC6996649 DOI: 10.1021/acscatal.9b04617
Source DB: PubMed Journal: ACS Catal Impact factor: 13.084
Scheme 1Biocatalytic Friedel–Crafts Acylation Investigated
Acyl donors 3a–3e were selected as initial probes to investigate acyltransferase variants to accept sterically more demanding substrates. Donors 3f–3s were investigated subsequently.
Figure 1Crystal structure with the butanoyl residue modeled into the active site by extending the acetyl moiety manually and introducing mutation F148V by PyMOL mutation wizard. Figures were prepared using PyMOL.
Conversions of ATase Variants with Acyl Donor Substrates 3a–3e
| conv. [%] | |||||||
|---|---|---|---|---|---|---|---|
| entry | specific
activity [mU/mg] | ||||||
| 1 | wild type | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | 55.4 ± 4.1 |
| 2 | F148A | 52.5 ± 2.0 | 6.1 ± 0.1 | 54.8 ± 0.9 | 1.0 ± 1.7 | <0.1 | 8.6 ± 1.1 |
| 3 | F148V | 66.8 ± 1.5 | 8.8 ± 3.6 | 24.0 ± 0.9 | 1.0 ± 1.7 | <0.1 | 10.2 ± 0.8 |
| 4 | F148A/L383A | 2.3 ± 0.6 | <0.1 | 19.1 ± 2.0 | 0.6 ± 0.5 | <0.1 | 7.4 ± 1.7 |
| 5 | F148A/L383V | 35.4 ± 2.7 | 2.8 ± 0.8 | 45.7 ± 5.1 | 0.8 ± 0.2 | <0.1 | 9.1 ± 0.8 |
| 6 | F148V/L383A | 2.3 ± 0.6 | <0.1 | 14.6 ± 0.4 | 0.9 ± 0.8 | <0.1 | 8.5 ± 3.5 |
| 7 | F148V/L383V | 37.5 ± 2.0 | 4.3 ± 1.2 | 16.9 ± 1.2 | 2.3 ± 0.3 | <0.1 | 4.0 ± 0.8 |
| 8 | F148V/Y386A | 21.3 ± 1.3 | 2.9 ± 0.8 | 10.4 ± 1.4 | 0.7 ± 0.7 | <0.1 | 4.9 ± 1.1 |
| 9 | F148V/Y386V | 29.2 ± 0.7 | 2.2 ± 1.0 | 17.7 ± 3.7 | 0.6 ± 0.6 | <0.1 | 9.3 ± 0.2 |
| 10 | F148V/L300A | 30.8 ± 0.5 | <0.1 | 21.2 ± 1.9 | 2.8 ± 0.2 | <0.1 | 12.5 ± 1.4 |
| 11 | F148V/L300V | 22.5 ± 2.2 | <0.1 | 19.2 ± 0.9 | 1.2 ± 1.0 | <0.1 | 19.1 ± 1.8 |
| 12 | F148V/W211A | 8.5 ± 1.3 | 2.0 ± 0.9 | 6.6 ± 0.5 | 1.0 ± 0.9 | <0.1 | 10.7 ± 1.5 |
| 13 | F148V/W211A/Y386A | 2.2 ± 0.2 | 1.1 ± 0.1 | 1.8 ± 1.2 | <0.1 | <0.1 | 8.7 ± 0.9 |
Conditions: cell-free Escherichia coli extract containing ATase variant (1.5 mg total protein) in K-phosphate-buffer (100 mM, pH 7.5, total volume 1 mL), resorcinol (1, 0.01 mmol), donor 3a–3e (0.015 mmol), imidazole (100 mM added from a 1 M stock solution prepared in the reaction buffer), 35 °C, 750 rpm, 24 h. Conversions were determined based on three experiments by high performance liquid chromatography (HPLC) using calibration curves with authentic samples.
Specific activity refers to the activity of the enzyme for the disproportionation of monoacetylphloroglucinol into diacetylphloroglucinol and phloroglucinol.
Cell-free E. coli extract containing ATase variant (3 mg total protein).
Acyltransferase F148V-Catalyzed Acylation of 1 with Butanoyl Donors (3f–3h) under Varied Conditionsa
| entry | donor | donor conc. [mM] | acceptor conc. [mM] | additives | enzyme loading [mg] | conv. [%] |
|---|---|---|---|---|---|---|
| 1 | 100 | 10 | Im 100 mM | 1.5 | 18.2 ± 5.4 | |
| 2 | 100 | 10 | Im 100 mM | 1.5 | 13.7 ± 2.1 | |
| 3 | 100 | 10 | Im 100 mM | 1.5 | 30.4 ± 2.8 | |
| 4 | 100 | 10 | Im 100 mM | 3 | 34.5 ± 2.8 | |
| 5 | 100 | 10 | Im 100 mM | 6 | 53.7 ± 0.2 | |
| 6 | 100 | 10 | DMSO (10% v/v) | 1.5 | 32.1 ± 3.0 | |
| 7 | 100 | 10 | 1.5 | 27.3 ± 2.3 | ||
| 8 | 15 | 10 | Im 100 mM | 1.5 | 13.3 ± 1.2 | |
| 9 | 50 | 10 | Im 100 mM | 1.5 | 28.5 ± 1.0 | |
| 10 | 100 | 10 | Im 100 mM; Triton X-100 | 1.5 | 31.4 ± 3.1 | |
| 11 | 100 | 10 | Im 100 mM; Tween 40 | 1.5 | 34.5 ± 0.6 |
Reaction conditions: cell-free E. coli extract containing ATase F148A (1.5–6 mg total protein) in KPi-buffer (100 mM, pH 7.5, total volume 1 mL), resorcinol (1, 0.01 mmol), donor 3d–3h (0.1 mmol) with or without imidazole (Im, 100 mM added from a 1 M stock solution prepared in the reaction buffer), or with DMSO (10% v/v), or Triton X-100 (0.25 mM), or Tween 40 (0.03 mM), 35 °C, 750 rpm, 24 h.
Scheme 2Biocatalytic Friedel–Crafts Acylation of Resorcinol Using Phenyl Esters as Donors
Values before brackets represent conversions performed on an analytical scale. Values in brackets represent isolated yield from reaction performed on 0.25 mmol scale for 1. Reaction conditions for semi-preparative scale: ATase F148V, 30 °C, 120 rpm, 24 h, horizontal tube position.
Kinetic Parameters for Wild-Type PpATaseCH and Variant F148V in the Biocatalytic Friedel–Crafts-Type Acylation
| substrate | enzyme variant | ||||
|---|---|---|---|---|---|
| MAPG | 0.29 ± 0.04 | 4.83 ± 0.57 | 72 ± 8 | 251 ± 15 | |
| MAPG | F148V | 0.24 ± 0.09 | 0.82 ± 0.15 | 7.2 ± 1.9 | 31 ± 4 |
| MBPG | <0.014 | ||||
| MBPG | F148V | 0.54 ± 0.07 | 0.62 ± 0.11 | 5.3 ± 0.6 | 9.9 ± 0.8 |
| F148V | 3.2 ± 0.1 | 0.04 ± 0.02 | 0.012 ± 0.002 | 0.0037 ± 0.0006 | |
| F148V | 5.0 ± 1.0 | 0.58 ± 0.23 | 0.188 ± 0.016 | 0.0387 ± 0.0085 |
Spectrophotometric assay: potassium phosphate buffer (100 mM, pH 7.5) and substrate 0.04–1.6 mM (added from a 40 mM stock solution prepared in DMSO) were added to a cuvette and preheated to 35 °C. The reaction (1 mL total volume) was started by the addition of purified enzyme (0.18 mg). The reaction was followed for over 1 min. An increase in absorption is recorded because of the formation of DAPG (λ = 370 nm) or DBPG (λ = 370 nm). All reactions were performed in triplicates.
HPLC assay: potassium phosphate buffer (100 mM, pH 7.5), donor 3h or 3k 0.5–25 mM (added from a 50 mM stock solution prepared in DMSO), resorcinol (1, 0.275 mg, 10 mM), imidazole (100 mM, added from a 1 M stock solution in phosphate buffer) were added to an Eppendorf tube. The reaction (0.25 mL total volume) was started by the addition of purified enzyme (0.75 mg). The reaction mixture was shaken (5 min for 3k and 60 min for 3h) at 35 °C and 750 rpm in an orbital shaker. Reactions were quenched by addition of acetonitrile (0.25 mL). The precipitated protein was removed by centrifugation (20 min, 14 000 rpm), and the supernatant was subjected to HPLC for determination of conversions.
Reaction rates were lower than the detection limit, V < 0.014 mmol min–1.